Departamento académico
(FM) Inmunología
Publications (12) Publications in which a researcher has participated
2011
-
BiovaxID®: A customized idiotype vaccine for the treatment of B-cell lymphoma
Expert Review of Vaccines, Vol. 10, Núm. 12, pp. 1661-1669
-
Carcinoma-derived Interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation
PLoS ONE, Vol. 6, Núm. 3
-
Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes
PLoS ONE, Vol. 6, Núm. 12
-
Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens
Leukemia Research, Vol. 35, Núm. 10, pp. 1412-1415
-
Direct effects of type I interferons on cells of the immune system
Clinical Cancer Research, Vol. 17, Núm. 9, pp. 2619-2627
-
IV Latin American consensus on the treatment of lymphedema
Journal Phlebology and Lymphology, Vol. 4, Núm. 1, pp. 13-16
-
Idiotype vaccines for lymphoma therapy
Expert Review of Vaccines, Vol. 10, Núm. 6, pp. 801-809
-
Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
International Journal of Cancer, Vol. 128, Núm. 1, pp. 105-118
-
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
Journal of Immunology, Vol. 187, Núm. 11, pp. 6130-6142
-
Simb16: Modeling induced immune system response against B16-melanoma
PLoS ONE, Vol. 6, Núm. 10
-
Stem cell transplant and idiotypic vaccination for B-cell malignancies
Current Topics in Medicinal Chemistry, Vol. 11, Núm. 13, pp. 1653-1660
-
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo
International Journal of Cancer, Vol. 129, Núm. 2, pp. 374-386